Delaware (State or other jurisdiction of incorporation) |
001-34637 (Commission File Number) |
20-1852016 (I.R.S. Employer Identification No.) |
25801 Industrial Boulevard, Suite B, Hayward, California (Address of principal executive offices) |
94545 (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 | Results of Operations and Financial Condition. |
Item 9.01 | Financial Statements and Exhibits. |
Exhibit No. | Description | |||
99.1 | Press Release, dated November 2, 2010 |
2
Date: November 2, 2010 | Anthera Pharmaceuticals, Inc. |
|||
By: | /s/ Christopher P. Lowe | |||
Christopher P. Lowe | ||||
Chief Financial Officer and Vice President of Administration |
Exhibit No. | Description | |||
99.1 | Press Release, dated November 2, 2010 |